The clinical investigation of Citrullus colocynthis (L.) Schrad. fruit in treatment of type II diabetic patients; a randomized, double-blind, placebo-controlled study

Journal of Medicinal Plants

Volumn 5, Issue SUPPL. 2, 2006, Pages 31-35

  Fallah Huseini, H ^a   Heshmat, R ^c   Larijani, B ^b   Fakhrzadeh, ^f   Darvishzadeh, F ^b   Jafariazar, Z ^d   Shikh Samani, A H ^e   Rahmani, M ^b  

^a Institute of Medicinal Plants Iran   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^f NONE

Author keywords

Citrullus colocynthis; Clinical trial; Diabetes; Herbal medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; COLOCYNTH; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIARRHEA; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

CITRULLUS COLOCYNTHIS;

EID: 33745055251     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Goldfain D, Lavergne A, Galian A, Chauveinc L and Prudhomme F. Peculiar acute toxic colitis after ingestion of colocynth: a clinicopathological study of three cases. Gut. 1989; 30: 1412-1418.
2. Al Faraj S. Haemorrhagic colitis induced by Citrullus colocynthis. Annual. Tropen. Parasitology. 1995; 89, 695-696.
3. Al-Yahya MA, AL-Farhan AH and Adam SE. Preliminary toxicity study on the individual and combined effects of Citrullus colocynthis and Nerium oleander in rats. Fitoterapia. 2000; 71: 385-391.
4. Diwan FH, Abdel-Hassan Ia and Mohammed ST. Effect of saponin on mortality and histopathological changes in mice. Eastern Mediterranean Health Journal. 2000; 6: 345-351.
5. Bakhiet AO and Adam SEI. An estimation of Citrullus colocynthis toxicity for chicks. Vet. Hum. Toxicol. 1995; 37: 356-359.
6. Elawad AA, Abdel Bari EM, Mahmoud OM, Adam SE. The effect of Citrullus colocynthis on sheep. Vet. Hum. Toxicol. 1984; 26 (6): 481-485.
7. Wasfi IA. Some pharmacological studies on Citrullus colocynthis. Journal of herbs, spices and medical plants 1994; 2: 65-79.
8. Afifia MD, Sayed MS and Balbaa SI. Nitrogenous bases of different organs of Citrullus colocynthis. Planta Medica. 1973; 24: 260-265.
9. Darwish SM, Balbaa ST and Afifi MS. The glycosidal content of the different organs of Citrullus colocynthis. Planta Medica. 1974; 26: 293-298.
10. Ziyyat A, Legssyer A, Mckhfi H, Dassouli A, Serhrouchni M and Benjelloum W. Phytotherapy of hypertension and diabetes in oriental morocco. J. Ethnopharmacol. 1997; 58: 45-54.
11. Abdel-Hassan IA, Abdel-Barry JA and Tariq Mohammeda S. The hypoglycaemic and antihyperglycaemic effect of citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits. J. Ethnopharmacol. 2000; 71: 325-330.
12. Nmila R, Gross R, Rchid H, Roye M, Manteghetti M, Petit P, Tijane M, Ribes G and Sauvaire Y. Insulinotropic effect of Citrullus colocynthis fruit extracts. Planta Med. 2000; 66: 418-423.
13. American diabetes Association. Screening for type 2 Diabetes. Diabetes Care. 2003; 26 (S1): S21-S24.
14. Ramachandran B, Ravi K, Narayanan V, Kandaswamy M and Subramanian S. Protective effect of macrocyclic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats. Chem. Biol. Interact. 2004; 149 (1): 9-21.
15. Al-Ghaithi F, El-Ridi MR, Adeghate E, Amiri MH. Biochemical effects of Citrullus colocynthis in normal and diabetic rats. Mol. Cell Biochem. 2004; 261: 143-149.
16. McGarry JD. Banting Lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002; 51, 7-18.
17. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997; 46: 3-10.
18. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab. Res. Rev. 2001; 17: 189-212.
19. Paolisso G and Giugliano D. Oxidative stress and insulin action. Is there a relationship? Diabetologia. 1996; 39: 357-363.
20. Barth A, Muller D and Durrling K. In vitro investigation of a standardized dried extract of Citrullus colocynthis on liver toxicity in adult rats. Exp. Toxicol. Pathol 2002; 54: 223-230.
21. Gebhardt R. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung. 2003; 53: 823-830.
22. Soto CP, Perez BL, Favari LP and Reyes JL. Prevention of alloxan-induced diabetes mellitus in the rat by siliymarin. Comparative pharmaqcology & Toxicology. 1998; 119: 125-129.
23. Packer L, Rosen P, Tritschler H, King GL and Azzi A (Eds): Antioxidants and Diabetes Management. New York, Marcel Dekker, 2000.